EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multicellular interaction of ovarian and cervical cancer patient-derived cells-A 3-dimensional model



Multicellular interaction of ovarian and cervical cancer patient-derived cells-A 3-dimensional model



Gynecologic Oncology 72(3): 520, March




(PDF 0-2 workdays service: $29.90)

Accession: 035349713

Download citation: RISBibTeXText



Related references

Altered mitogenic response of HUVEC to ovarian cancer patient-derived cells in 3-dimensional cultures. Molecular Biology of the Cell 8(SUPPL ): 229A, 1997

Development of a three-dimensional multiscale agent-based tumor model: simulating gene-protein interaction profiles, cell phenotypes and multicellular patterns in brain cancer. Journal of Theoretical Biology 244(1): 96-107, 2006

Optimisation of cervical tumour lysate loading of dendritic cells for development of a versatile and efficient anti-cervical cancer vaccine Use of Caski cells as a model source of cervical cancer derived tumour lysate. European Journal of Cancer 35(SUPPL 4): S355, Sept, 1999

Ovarian and cervical cancer patient derived xenografts: The past, present, and future. Gynecologic Oncology 138(2): 486-491, 2015

Construction of three-dimensional in vitro culture model of ovarian carcinoma and the study of its multicellular drug resistance. Journal of Huazhong University of Science and Technology. Medical Sciences 26(6): 741-743, 2007

Senescent fibroblasts promote neoplastic transformation of partially transformed ovarian epithelial cells in a three-dimensional model of early stage ovarian cancer. Neoplasia 12(4): 317-325, 2010

Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer. Oncotarget 5(18): 8750-8764, 2015

Biomechanical profile of cancer stem-like/tumor-initiating cells derived from a progressive ovarian cancer model. Nanomedicine 10(5): 1013-1019, 2015

p70 S6 kinase drives ovarian cancer metastasis through multicellular spheroid-peritoneum interaction and P-cadherin/b1 integrin signaling activation. Oncotarget 5(19): 9133-9149, 2015

Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions. Clinical & Experimental Metastasis 33(8): 839-852, 2016

An immunomagnetic-based method for the purification of ovarian cancer cells from patient-derived ascites. Gynecologic Oncology 82(1): 57-63, 2001

Establishment of a patient-derived orthotopic Xenograft (PDOX) model of HER-2-positive cervical cancer expressing the clinical metastatic pattern. Plos One 10(2): E0117417-E0117417, 2016

Generation of multicellular tumor spheroids of breast cancer cells: how to go three-dimensional. Analytical Biochemistry 437(1): 17-19, 2013

Expression of angiogenic factors and inhibitors by ovarian cancer patient-derived epithelila and mononuclear cells. Proceedings of the American Association for Cancer Research Annual Meeting (41): 166, March, 2000

B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer. Clinical Immunology 129(3): 471-481, 2008